Fort Washington Investment Advisors Inc. OH bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 677,753 shares of the company’s stock, valued at approximately $18,774,000. Fort Washington Investment Advisors Inc. OH owned approximately 0.39% of Option Care Health as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Norden Group LLC purchased a new stake in shares of Option Care Health in the fourth quarter valued at approximately $358,000. Cannell & Co. boosted its position in shares of Option Care Health by 2,478.1% during the 4th quarter. Cannell & Co. now owns 174,025 shares of the company’s stock worth $5,863,000 after purchasing an additional 167,275 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of Option Care Health by 22.5% during the 4th quarter. Victory Capital Management Inc. now owns 88,417 shares of the company’s stock worth $2,979,000 after purchasing an additional 16,240 shares during the period. Andina Capital Management LLC purchased a new position in shares of Option Care Health in the 4th quarter valued at about $257,000. Finally, Sheets Smith Wealth Management lifted its stake in shares of Option Care Health by 3.6% in the fourth quarter. Sheets Smith Wealth Management now owns 33,722 shares of the company’s stock valued at $1,136,000 after purchasing an additional 1,180 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Read Our Latest Report on OPCH
Option Care Health Stock Up 1.2 %
Shares of NASDAQ:OPCH opened at $32.02 on Friday. The company has a market capitalization of $5.57 billion, a P/E ratio of 21.07, a P/E/G ratio of 2.33 and a beta of 1.24. The stock’s fifty day simple moving average is $29.91 and its 200-day simple moving average is $30.55. Option Care Health, Inc. has a 52-week low of $26.11 and a 52-week high of $35.63. The company has a quick ratio of 1.39, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.
Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.03. The company had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period last year, the company earned $0.63 EPS. As a group, equities research analysts forecast that Option Care Health, Inc. will post 1.21 earnings per share for the current fiscal year.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Five stocks we like better than Option Care Health
- How to Calculate Stock Profit
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- How to Invest in the FAANG Stocks
- Why Dell Can Continue Winning in AI and Beyond
- 10 Best Airline Stocks to Buy
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.